Impact of Periodontal Treatment on Clinical Outcomes in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Interventio
Not Applicable
Recruiting
- Conditions
- Coronary artery disease
- Registration Number
- JPRN-UMIN000051921
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) Currently undergoing treatment for periodontal disease (PD) 2) Patients with cardiogenic shock, or hemodynamically or electrically unstable acute coronary syndrome (ACS) 3) Positive for COVID-19 4) Currently pregnant or breastfeeding 5) Carrying infectious diseases such as hepatitis virus or HIV.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The composite endpoint that includes cardiovascular death, non-fatal myocardial infarction, target lesion revascularization, and non-target lesion revascularization at 24 months
- Secondary Outcome Measures
Name Time Method Inflammatory markers at 12 months (high-sensitivity CRP, IL-6, TNF-alpha)